Next Generation News and Research

RSS

Declining PSA levels predict improved survival rates in men with non-metastatic castration-resistant prostate cancer

Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic castration-resistant prostate cancer (nmCRPC), reports The Journal of Urology, an Official Journal of the American Urological Association.

10 Feb 2023

UK HealthCare and SCH collaborate to expand cardiovascular services to the Morehead area

UK HealthCare and St. Claire HealthCare have announced a collaboration to expand cardiovascular services to the Morehead area.

10 Feb 2023

High-precision mechanical sensing system can measure in vivo biomechanical properties of tissue, single cell

Fiber sensing scientists at Shenzhen University have developed a compact fiber optical nanomechanical probe (FONP) for measuring in vivo biomechanical properties of tissue and even single cell.

10 Feb 2023

Scientists identify miRNAs associated with type 2 diabetes in humans

MicroRNA (miRNA) molecules in pancreatic islets have been thought to play important roles in type 2 diabetes, but until now scientists have not confidently identified which miRNAs are associated with the disease in humans.

10 Feb 2023

No new SARS-CoV-2 variants detected in China since COVID policy change

In a recent study published in The Lancet, researchers reported the trends in coronavirus disease 2019 (COVID-19) cases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in Beijing in 2022.

9 Feb 2023

Scientists find microRNAs in human pancreatic cells that are strongly linked with type 2 diabetes

In a new large-scale genetic analysis, scientists have found a set of small RNA molecules, called microRNAs, in human pancreatic cells that are strongly associated with type 2 diabetes.

9 Feb 2023

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Researchers describe a novel SARS-CoV-2 spike protein component vaccine called MT-001.

9 Feb 2023

COVID-19 vaccination increases saliva antibody levels after asymptomatic infection

Researchers correlate SARS-CoV-2 load and neutralizing capacity of all saliva immunoglobulins isotypes in asymptomatic individuals.

8 Feb 2023

The nature of the immune responses induced by various COVID-19 vaccines developed using different platforms and formulations

Researchers reviewed existing achievements and shortcomings in SARS-CoV-2 vaccine platforms, as well as future-generation vaccine considerations.

7 Feb 2023

Integrated NGS system can deliver accurate, genomics-based diagnoses to accelerate treatment for myeloid neoplasms

Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients. However, treatment initiation can be delayed by the variable and lengthy turnaround times involved in testing for these alterations.

7 Feb 2023

Gut hormone receptor polyagonists show promise for obesity and diabetes

A new paper in the Journal of Clinical Investigation describes drugs that could help lose weight and manage type 2 diabetes mellitus (T2DM).

6 Feb 2023

Researchers discover a new hexameric structure of the RepB protein and how it binds to DNA

In all living organisms, DNA replication is essential to ensure the genetic fidelity of the next generation. However, bacteria can also transfer genetic information horizontally to other bacteria.

3 Feb 2023

New nanotechnology-based test can detect and profile prostate cancers even in microscopic amounts

Cedars-Sinai Cancer investigators have developed a new nanotechnology-based test that can detect and profile prostate cancers - even in microscopic amounts.

2 Feb 2023

Integrated model helps enhance patient care for pediatric brain tumors

The Brain Tumor Center at Children's Hospital Los Angeles is one of the largest and most comprehensive pediatric brain tumor programs in the country, integrating experts from multiple specialty areas into a coordinated treatment team.

2 Feb 2023

Mays Cancer Center leads a study evaluating Phase I and Phase III clinical trials for breast cancer drug

The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer.

1 Feb 2023

Next Generation News and Research

Declining PSA levels predict improved survival rates in men with non-metastatic castration-resistant prostate cancer

UK HealthCare and SCH collaborate to expand cardiovascular services to the Morehead area

High-precision mechanical sensing system can measure in vivo biomechanical properties of tissue, single cell

Scientists identify miRNAs associated with type 2 diabetes in humans

No new SARS-CoV-2 variants detected in China since COVID policy change

Scientists find microRNAs in human pancreatic cells that are strongly linked with type 2 diabetes

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

COVID-19 vaccination increases saliva antibody levels after asymptomatic infection

The nature of the immune responses induced by various COVID-19 vaccines developed using different platforms and formulations

Integrated NGS system can deliver accurate, genomics-based diagnoses to accelerate treatment for myeloid neoplasms

Gut hormone receptor polyagonists show promise for obesity and diabetes

Researchers discover a new hexameric structure of the RepB protein and how it binds to DNA

New nanotechnology-based test can detect and profile prostate cancers even in microscopic amounts

Integrated model helps enhance patient care for pediatric brain tumors

Mays Cancer Center leads a study evaluating Phase I and Phase III clinical trials for breast cancer drug

Deep-learning based filter removes false positives, improves the accuracy of cancer diagnosis

Could novel lineages eventually dominate the viral population?

Breakthrough Omicron BA.1/BA.2 infections in the triple-vaccinated linked to broad-based immunity

CuSTOM; Creating a healthier society by accelerating the translation of organoid technology

Effectiveness of exome and genome sequencing to detect undiagnosed syndromes

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News